WallStreetZenWallStreetZen

NASDAQ: VALN
Valneva Se Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for VALN

Based on 2 analysts offering 12 month price targets for Valneva Se

Min Forecast
$13.00+53.66%
Avg Forecast
$15.50+83.22%
Max Forecast
$18.00+112.77%

Should I buy or sell VALN stock?

Based on 2 analysts offering ratings for Valneva Se.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VALN stock forecasts and price targets.

VALN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-08
lockedlocked$00.00+00.00%2025-08-25

1 of 1

Forecast return on equity

Is VALN forecast to generate an efficient return?

Company
26.12%
Industry
248.3%
Market
228.5%
VALN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VALN forecast to generate an efficient return on assets?

Company
8.77%
Industry
88.66%
VALN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VALN earnings per share forecast

What is VALN's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.54
Avg 2 year Forecast
-$0.32
Avg 3 year Forecast
$0.50

VALN revenue forecast

What is VALN's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$175.8M-16.97%
Avg 2 year Forecast
$197.3M-6.81%
Avg 3 year Forecast
$388.5M+83.57%
VALN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VALN revenue growth forecast

How is VALN forecast to perform vs Biotechnology companies and vs the US market?

Company
19.96%
Industry
98.52%
Market
25.72%
VALN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VALN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VALN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VALN$8.46$15.50+83.22%Strong Buy
DBVT$20.27$46.00+126.94%Strong Buy
NBY$5.43N/AN/A
FULC$12.78$17.00+33.02%Buy
GYRE$7.19$17.00+136.44%Strong Buy
View Top Biotech Stocks

Valneva Se Stock Forecast FAQ

Is Valneva Se Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: VALN) stock is to Strong Buy VALN stock.

Out of 2 analysts, 1 (50%) are recommending VALN as a Strong Buy, 1 (50%) are recommending VALN as a Buy, 0 (0%) are recommending VALN as a Hold, 0 (0%) are recommending VALN as a Sell, and 0 (0%) are recommending VALN as a Strong Sell.

If you're new to stock investing, here's how to buy Valneva Se stock.

What is VALN's earnings growth forecast for 2025-2027?

(NASDAQ: VALN) Valneva Se's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 42.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.51%.

Valneva Se's earnings in 2025 is -$117,425,287.On average, 8 Wall Street analysts forecast VALN's earnings for 2025 to be -$86,931,222, with the lowest VALN earnings forecast at -$108,221,495, and the highest VALN earnings forecast at -$69,911,995. On average, 8 Wall Street analysts forecast VALN's earnings for 2026 to be -$52,486,776, with the lowest VALN earnings forecast at -$81,166,122, and the highest VALN earnings forecast at -$28,987,901.

In 2027, VALN is forecast to generate $81,685,793 in earnings, with the lowest earnings forecast at -$1,591,493 and the highest earnings forecast at $134,708,479.

What is VALN's revenue growth forecast for 2025-2027?

(NASDAQ: VALN) Valneva Se's forecast annual revenue growth rate of 19.96% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 98.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.72%.

Valneva Se's revenue in 2025 is $206,796,551.On average, 8 Wall Street analysts forecast VALN's revenue for 2025 to be $28,541,308,252, with the lowest VALN revenue forecast at $26,275,867,284, and the highest VALN revenue forecast at $31,716,173,551. On average, 8 Wall Street analysts forecast VALN's revenue for 2026 to be $32,032,848,095, with the lowest VALN revenue forecast at $27,612,396,256, and the highest VALN revenue forecast at $40,105,613,006.

In 2027, VALN is forecast to generate $63,097,808,865 in revenue, with the lowest revenue forecast at $51,928,129,312 and the highest revenue forecast at $72,658,132,147.

What is VALN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: VALN) forecast ROA is 8.77%, which is lower than the forecast US Biotechnology industry average of 88.66%.

What is VALN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year VALN price target, the average VALN price target is $15.50, with the highest VALN stock price forecast at $18.00 and the lowest VALN stock price forecast at $13.00.

On average, Wall Street analysts predict that Valneva Se's share price could reach $15.50 by Sep 8, 2026. The average Valneva Se stock price prediction forecasts a potential upside of 83.22% from the current VALN share price of $8.46.

What is VALN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: VALN) Valneva Se's current Earnings Per Share (EPS) is -$1.49. On average, analysts forecast that VALN's EPS will be -$0.54 for 2025, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.43. On average, analysts forecast that VALN's EPS will be -$0.32 for 2026, with the lowest EPS forecast at -$0.50, and the highest EPS forecast at -$0.18. In 2027, VALN's EPS is forecast to hit $0.50 (min: -$0.01, max: $0.83).

What is VALN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: VALN) forecast ROE is 26.12%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.